| abstract |
Pharmaceutical compositions and methods comprising a therapeutic agent that generates or produces reactive oxygen species ("ROS") in a disease microenvironment, and at least one kinase inhibitor for the treatment of mammalian cancer, dysplastic disorders, neoplastic, or hyperproliferative disorders and methods of using thereof for the treatment of mammalian cancer dysplastic disorders, neoplastic, or hyperproliferative disorders. |